The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Resistance to rifampicin: a review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Jin, D. J., & Gross, C. A. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90517-7 · Cited by 683
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Koller, W. C., Lyons, K., Pahwa, R., & Sf, S. W. (2002) · Cited by 421
Heil, A., & Zillig, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80519-1 · Cited by 370
David, H. L. (1970) · Applied Microbiology · doi:10.1128/aem.20.5.810-814.1970 · Cited by 317
Kapur, V, Li, L. L., Iordanescu, S., Hamrick, M. R., Wanger, A., Kreiswirth, B. N., & Musser, J. M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.1095-1098.1994 · Cited by 317
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis
Billington, O. J., McHugh, T. D., & Gillespie, S. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1866 · Cited by 251
Heep, M., Brandstätter, B., Rieger, U., Lehn, N., Richter, E., Rüsch-Gerdes, S., & Niemann, S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.107-110.2001 · Cited by 240
Aubry-Damon, H., Soussy, C.-J., & Courvalin, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2590 · Cited by 225
Zhou, Y. N., & Jin, D. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2908 · Cited by 215
Severinov, K., Soushko, M., Goldfarb, A., & Nikiforov, V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82407-3 · Cited by 203
Molecular basis of rifampin resistance in Mycobacterium leprae
Honore, N., & Cole, S. T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.414 · Cited by 198
OVCHINNIKOV, Y. A., MONASTYRSKAYA, G. S., GUBANOV, V. V., GURYEV, S. O., CHERTOV, O. Y., MODYANOV, N. N., GRINKEVICH, V. A., MAKAROVA, I. A., MARCHENKO, T. V., POLOVNIKOVA, I. N., et al. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb05381.x · Cited by 178
Landick, R., Stewart, J., & Lee, D. N. (1990) · Genes & Development · doi:10.1101/gad.4.9.1623 · Cited by 168
Jin, D. J., & Gross, C. A. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.9.5229-5231.1989 · Cited by 165
Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis
Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S.-I. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08515.x · Cited by 154
A rifampicin resistent rna‐polymerase from E. coli altered in the β‐subunit
Rabussay, D., & Zillig, W. (1969) · FEBS Letters · doi:10.1016/0014-5793(69)80305-4 · Cited by 150
Ohno, H., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.1053 · Cited by 149
Yang, B., Koga, H., Ohno, H., Ogawa, K., Fukuda, M., Hirakata, Y., Maesaki, S., Tomono, K., Tashiro, T., & Kohno, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.621 · Cited by 148
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase
Campbell, E. A., Pavlova, O. A., Zenkin, N., Leon, F., Irschik, H., Jansen, R., Severinov, K., & Darst, S. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600499 · Cited by 147
O’Neill, A. J., Huovinen, T., Fishwick, C. W. G., & Chopra, I. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.298-309.2006 · Cited by 143
Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis
Pang, Y., Lu, J. L., Wang, Y., Song, Y., Wang, S., & Zhao, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01024-12 · Cited by 136
Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns
Tupin, A., Gualtiéri, M., Roquet, F., Morichaud, Z., Brodolin, K. L., & Léonetti, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.017 · Cited by 130
Sonenshein, A. L., Cami, B., Brevet, J., & Cote, R. (1974) · Journal of Bacteriology · doi:10.1128/jb.120.1.253-265.1974 · Cited by 129
PARENTI, F., PAGANI, H., & BERETTA, G. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.247 · Cited by 128
Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
Watanabe, Y., Cui, L., Katayama, Y., Kozue, K., & Hiramatsu, K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02144-10 · Cited by 127
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus
O’Neill, A. J., Cove, J. H., & Chopra, I. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.647 · Cited by 123
Li, J., Munsiff, S. S., Driver, C. R., & Sackoff, J. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430377 · Cited by 122
Tanaka, Y., Kasahara, K., Hirose, Y., Murakami, K., Kugimiya, R., & Ochi, K. (2013) · Journal of Bacteriology · doi:10.1128/jb.00147-13 · Cited by 115
Wichelhaus, T. A., Schäfer, V., Brade, V., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2813 · Cited by 113
Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus
Wichelhaus, T. A., Böddinghaus, B., Besier, S. M., Schäfer, V., Brade, V., & Ludwig, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3381-3385.2002 · Cited by 111
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis
Ängeby, K., Juréen, P., Kahlmeter, G., Hoffner, S. E., & Schön, T. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.096644 · Cited by 106
Integron-Mediated Rifampin Resistance in Pseudomonas aeruginosa
Tribuddharat, C., & Fennewald, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.960 · Cited by 103
Yanofsky, C., & Horn, V. (1981) · Journal of Bacteriology · doi:10.1128/jb.145.3.1334-1341.1981 · Cited by 100
Kurabachew, M., Lu, S., Krastel, P., Schmitt, E. K., Suresh, B. L., Goh, A., Knox, J. E., L., N., Jiřiček, J., Beer, D., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn269 · Cited by 99
Çavuşoğlu, C., Karaca-Derici, Y., & Bilgiç, A. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00917.x · Cited by 79
Contribution ofrpoB2RNA Polymerase β Subunit Gene to Rifampin Resistance inNocardiaSpecies
Ishikawa, J., Chiba, K., Kurita, H., & Satoh, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1342-1346.2006 · Cited by 78
Perkins, A. E., & Nicholson, W. L. (2007) · Journal of Bacteriology · doi:10.1128/jb.00901-07 · Cited by 74
Lipiarmycin, a new antibiotic from Actinoplanes. III. Mechanism of action.
SERGIO, S., PIRALI, G., White, R. J., & PARENTI, F. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.543 · Cited by 73
Andersen, S. J., Quan, S., Gowan, B., & Dabbs, E. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.218 · Cited by 71
Structural Perspective on Mutations Affecting the Function of Multisubunit RNA Polymerases
Trinh, V. Q., Langelier, M.-F., Archambault, J., & Coulombe, B. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.12-36.2006 · Cited by 71
Molecular characterization of rifampin-resistant Neisseria meningitidis
CARTER, P. E., Abadi, F. J. R., Yakubu, D. E., & Pennington, T. H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1256 · Cited by 70
Xu, M., Zhou, Y. N., Goldstein, B. P., & Jin, D. J. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.8.2783-2792.2005 · Cited by 70
Self-citationCharacterization of Mutations in the rpoB Gene in Naturally Rifampin-Resistant Rickettsia Species
Drancourt, M., & Raoult, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2400 · Cited by 64
Severinov, K., MUSTAEV, A. A., Severinova, E., Kozlov, M. V., Darst, S. A., & Goldfarb, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29428 · Cited by 60
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds.
MUSTAEV, A. A., ZAYCHIKOV, E. F., Severinov, K. V., Kashlev, M., Polyakov, A., Nikiforov, V., & Goldfarb, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12036 · Cited by 59
Rifampin Resistance in Mycobacterium kansasii Is Associated with rpoB Mutations
Klein, J. L., Brown, T. J., & French, G. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3056-3058.2001 · Cited by 59
Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfections
Vall-Spinosa, A., Lester, W. T., Moulding, T., Davidson, P. T., & McClatchy, J. K. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009172831202 · Cited by 58
Molecular Basis of Rifampin Resistance inStreptococcus pneumoniae
Padayachee, T., & Klugman, K. P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2361 · Cited by 53
Hoshino, Y., Fujii, S., Shinonaga, H., et al. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2009.116 · Cited by 49
Stefanelli, P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.2.219 · Cited by 46
rpoB mutation in Escherichia coli alters control of ribosome synthesis by guanosine tetraphosphate
Little, R., Ryals, J. A., & Bremer, H. J. (1983) · Journal of Bacteriology · doi:10.1128/jb.154.2.787-792.1983 · Cited by 43
Gaurivaud, P., Laigret, F., & Bové, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.858 · Cited by 39
Villar, M., Marimón, J. M., García-Arenzana, J. M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr059 · Cited by 30
Plasmid-mediated rifampicin resistance in Pseudomonas fluorescens
Chandrasekaran, S., & Lalithakumari, D. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-3-197 · Cited by 30
Morishita, T., & Yura, T. (1976) · Journal of Bacteriology · doi:10.1128/jb.125.2.416-422.1976 · Cited by 20
Natural Rifampin Resistance in Treponema spp. Correlates with Presence of N531 in RpoB Rif Cluster I
Stamm, L. V., Bergen, H. L., & Shangraw, K. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2973-2974.2001 · Cited by 15
Cited by
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 780
Pulingam, T., Parumasivam, T., Gazzali, A. M., Sulaiman, A. M., Chee, J. Y., Lakshmanan, M., Chin, C. F., & Sudesh, K. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106103 · Cited by 550
Mechanisms and clinical relevance of bacterial heteroresistance
Andersson, D. I., Nicoloff, H., & Hjort, K. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0218-1 · Cited by 513
Antimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
Metadata
- Authors
- Goldstein, B. P.
- Venue
- The Journal of Antibiotics
- Published
- 2014-08-13
- Volume
- 67
- Issue
- 9
- Pages
- 625-630
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2057434770
- Cited by
- 409
- References
- 59
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.